Increased risk of cancer after Bell's palsy: A 5-year follow-up study

Jau-Jiuan Sheu, Joseph J. Keller, Herng-Ching Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Reactivation of latent herpes simplex virus (HSV) type I or varicella-zoster virus (VZV) has been recognized as the most common pathomechanism underlying Bell's palsy. There is also increased reactivation of HSV or VZV in patients with immunosuppressed states and in cancer patients. The purpose of this study was to investigate the risk for cancer during a 5-year follow-up period after diagnosis of Bell's palsy by using a population-based dataset in Taiwan. We used data from the Longitudinal Health Insurance Database. We identified 2,618 patients with Bell's palsy as the study cohort and randomly selected 13,090 patients to be used as a comparison cohort. Cox proportional hazards regression was performed to compare the 5-year risk of subsequent cancer between the study and comparison cohorts. We found that the incidence of cancer was 1.55 (95 % CI 1.35-1.78) per 100 person-years for patients with Bell's palsy and 1.09 (95 % CI 1.02-1.18) per 100 person-years for comparison patients. After censoring cases that died from non-cancer causes during the follow-up period and adjusting for urbanization, monthly income, geographic region, and diabetes, the hazard ratio (HR) for cancer during the 5-year follow-up period for patients with Bell's palsy was 1.43 times that for comparison patients (95 % CI 1.22-1.73). There was a particularly increased risk of oral cancer (HR = 2.49; 95 % CI 1.54-4.03) for patients with Bell's palsy compared with the other patients. We conclude that patients with Bell's palsy were at significant risk of cancer during a 5-year follow-up period after diagnosis.

Original languageEnglish
Pages (from-to)215-220
Number of pages6
JournalJournal of Neuro-Oncology
Volume110
Issue number2
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Bell Palsy
Neoplasms
Human Herpesvirus 3
Simplexvirus
Cohort Studies
Urbanization
Mouth Neoplasms
Health Insurance
Taiwan

Keywords

  • Bell's palsy
  • Cancer
  • Oral cancer

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Increased risk of cancer after Bell's palsy : A 5-year follow-up study. / Sheu, Jau-Jiuan; Keller, Joseph J.; Lin, Herng-Ching.

In: Journal of Neuro-Oncology, Vol. 110, No. 2, 11.2012, p. 215-220.

Research output: Contribution to journalArticle

@article{214c2b471e52440f8c9a058a28246ea2,
title = "Increased risk of cancer after Bell's palsy: A 5-year follow-up study",
abstract = "Reactivation of latent herpes simplex virus (HSV) type I or varicella-zoster virus (VZV) has been recognized as the most common pathomechanism underlying Bell's palsy. There is also increased reactivation of HSV or VZV in patients with immunosuppressed states and in cancer patients. The purpose of this study was to investigate the risk for cancer during a 5-year follow-up period after diagnosis of Bell's palsy by using a population-based dataset in Taiwan. We used data from the Longitudinal Health Insurance Database. We identified 2,618 patients with Bell's palsy as the study cohort and randomly selected 13,090 patients to be used as a comparison cohort. Cox proportional hazards regression was performed to compare the 5-year risk of subsequent cancer between the study and comparison cohorts. We found that the incidence of cancer was 1.55 (95 {\%} CI 1.35-1.78) per 100 person-years for patients with Bell's palsy and 1.09 (95 {\%} CI 1.02-1.18) per 100 person-years for comparison patients. After censoring cases that died from non-cancer causes during the follow-up period and adjusting for urbanization, monthly income, geographic region, and diabetes, the hazard ratio (HR) for cancer during the 5-year follow-up period for patients with Bell's palsy was 1.43 times that for comparison patients (95 {\%} CI 1.22-1.73). There was a particularly increased risk of oral cancer (HR = 2.49; 95 {\%} CI 1.54-4.03) for patients with Bell's palsy compared with the other patients. We conclude that patients with Bell's palsy were at significant risk of cancer during a 5-year follow-up period after diagnosis.",
keywords = "Bell's palsy, Cancer, Oral cancer",
author = "Jau-Jiuan Sheu and Keller, {Joseph J.} and Herng-Ching Lin",
year = "2012",
month = "11",
doi = "10.1007/s11060-012-0954-9",
language = "English",
volume = "110",
pages = "215--220",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Increased risk of cancer after Bell's palsy

T2 - A 5-year follow-up study

AU - Sheu, Jau-Jiuan

AU - Keller, Joseph J.

AU - Lin, Herng-Ching

PY - 2012/11

Y1 - 2012/11

N2 - Reactivation of latent herpes simplex virus (HSV) type I or varicella-zoster virus (VZV) has been recognized as the most common pathomechanism underlying Bell's palsy. There is also increased reactivation of HSV or VZV in patients with immunosuppressed states and in cancer patients. The purpose of this study was to investigate the risk for cancer during a 5-year follow-up period after diagnosis of Bell's palsy by using a population-based dataset in Taiwan. We used data from the Longitudinal Health Insurance Database. We identified 2,618 patients with Bell's palsy as the study cohort and randomly selected 13,090 patients to be used as a comparison cohort. Cox proportional hazards regression was performed to compare the 5-year risk of subsequent cancer between the study and comparison cohorts. We found that the incidence of cancer was 1.55 (95 % CI 1.35-1.78) per 100 person-years for patients with Bell's palsy and 1.09 (95 % CI 1.02-1.18) per 100 person-years for comparison patients. After censoring cases that died from non-cancer causes during the follow-up period and adjusting for urbanization, monthly income, geographic region, and diabetes, the hazard ratio (HR) for cancer during the 5-year follow-up period for patients with Bell's palsy was 1.43 times that for comparison patients (95 % CI 1.22-1.73). There was a particularly increased risk of oral cancer (HR = 2.49; 95 % CI 1.54-4.03) for patients with Bell's palsy compared with the other patients. We conclude that patients with Bell's palsy were at significant risk of cancer during a 5-year follow-up period after diagnosis.

AB - Reactivation of latent herpes simplex virus (HSV) type I or varicella-zoster virus (VZV) has been recognized as the most common pathomechanism underlying Bell's palsy. There is also increased reactivation of HSV or VZV in patients with immunosuppressed states and in cancer patients. The purpose of this study was to investigate the risk for cancer during a 5-year follow-up period after diagnosis of Bell's palsy by using a population-based dataset in Taiwan. We used data from the Longitudinal Health Insurance Database. We identified 2,618 patients with Bell's palsy as the study cohort and randomly selected 13,090 patients to be used as a comparison cohort. Cox proportional hazards regression was performed to compare the 5-year risk of subsequent cancer between the study and comparison cohorts. We found that the incidence of cancer was 1.55 (95 % CI 1.35-1.78) per 100 person-years for patients with Bell's palsy and 1.09 (95 % CI 1.02-1.18) per 100 person-years for comparison patients. After censoring cases that died from non-cancer causes during the follow-up period and adjusting for urbanization, monthly income, geographic region, and diabetes, the hazard ratio (HR) for cancer during the 5-year follow-up period for patients with Bell's palsy was 1.43 times that for comparison patients (95 % CI 1.22-1.73). There was a particularly increased risk of oral cancer (HR = 2.49; 95 % CI 1.54-4.03) for patients with Bell's palsy compared with the other patients. We conclude that patients with Bell's palsy were at significant risk of cancer during a 5-year follow-up period after diagnosis.

KW - Bell's palsy

KW - Cancer

KW - Oral cancer

UR - http://www.scopus.com/inward/record.url?scp=84867845942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867845942&partnerID=8YFLogxK

U2 - 10.1007/s11060-012-0954-9

DO - 10.1007/s11060-012-0954-9

M3 - Article

C2 - 22890970

AN - SCOPUS:84867845942

VL - 110

SP - 215

EP - 220

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -